Investigator Initiated Trial Confirms Safety of Silk-Elastin for Meniscus Injury-Multi-Center Collaborative Corporate Clinical Trial to Seek Approval for Meniscal Repair and Regeneration Medical Devices-
- 2024/05/21 News
실시간 바카라emical Industries, Ltd. and Hiroshima University are pleased to announce that an investigator-initiated clinical trial was conducted targeting patients with meniscus injuries (meniscus suture) using new treatment method using Silk-Elastin at Hiroshi, and its safety was confirmed. Silk-Elastin is a functional protein with high potential as a scaffold for promoting repair and regeneration of living tissue.
Based on these results, 실시간 바카라emical, together with Hiroshima University and others, will conduct a corporate clinical trial to confirm its efficacy and promote research and development toward commercialization.
>Release:Investigator Initiated Trial Confirms Silk-Elastin for Safety of Meniscus Injury